Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02205801 · OUTCOME

Total Pain Medication Utilization

Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy · Source last updated 2018-03-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
mg
Interval / dispersion
Standard Deviation
Time frame
At follow up appointment 1-2 weeks postoperatively

What was measured

Total operative opioid dosages administered converted to effective mg of Hydromorphine.

Groups in this outcome

Superficial Cervical Block, Active

After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.25% Marcaine. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine

Superficial Cervical Block, Placebo

After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.9% saline. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline

Local Wound Infiltration, Active

After induction of general anesthesia the surgeon will perform a local wound infiltration using 0.25% Marcaine. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine

Local Wound Infiltration, Placebo

After induction of general anesthesia the surgeon will perform local wound infiltration using 0.9% Saline. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Superficial Cervical Block, Active11
Superficial Cervical Block, Placebo8
Local Wound Infiltration, Active9
Local Wound Infiltration, Placebo8

Reported measurements

Source class 1
Values in mg · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Superficial Cervical Block, Active0.560.43Not reportedNot reportedNot reported
Superficial Cervical Block, Placebo0.710.4Not reportedNot reportedNot reported
Local Wound Infiltration, Active0.840.47Not reportedNot reportedNot reported
Local Wound Infiltration, Placebo0.790.52Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        0.43
        value
        0.56
      2. group Id
        OG001
        spread
        0.4
        value
        0.71
      3. group Id
        OG002
        spread
        0.47
        value
        0.84
      4. group Id
        OG003
        spread
        0.52
        value
        0.79
denoms
  1. counts
    1. group Id
      OG000
      value
      11
    2. group Id
      OG001
      value
      8
    3. group Id
      OG002
      value
      9
    4. group Id
      OG003
      value
      8
    units
    Participants
description
Total operative opioid dosages administered converted to effective mg of Hydromorphine.
dispersion Type
Standard Deviation
groups
  1. description
    After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.25% Marcaine. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
    id
    OG000
    title
    Superficial Cervical Block, Active
  2. description
    After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.9% saline. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
    id
    OG001
    title
    Superficial Cervical Block, Placebo
  3. description
    After induction of general anesthesia the surgeon will perform a local wound infiltration using 0.25% Marcaine. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
    id
    OG002
    title
    Local Wound Infiltration, Active
  4. description
    After induction of general anesthesia the surgeon will perform local wound infiltration using 0.9% Saline. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
    id
    OG003
    title
    Local Wound Infiltration, Placebo
param Type
MEAN
reporting Status
POSTED
time Frame
At follow up appointment 1-2 weeks postoperatively
title
Total Pain Medication Utilization
type
SECONDARY
unit Of Measure
mg

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice